VIP
Research use only.
VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide widely distributed throughout the central and peripheral nervous systems. It is extensively studied for its role in modulating immune responses, regulating smooth muscle activity, and facilitating communication between the nervous, endocrine, and immune systems.
Product overview
VIP is a research-grade peptide composed of a 28-amino-acid sequence, engineered for stability and biological activity. Preclinical and clinical research associate VIP with cytokine modulation, vasodilatory signaling, and regulation of epithelial and mucosal function. Its broad physiological activity makes it a valuable tool for studying integrated system responses across multiple biological pathways.
Key research features
Neuroimmune and inflammatory pathway research:
VIP is widely investigated for its ability to regulate cytokine production and immune cell signaling, making it relevant in experimental models of inflammation and immune balance.
Vascular and smooth muscle signaling:
Studies suggest VIP plays a key role in vasodilation and smooth muscle relaxation, supporting research into blood flow regulation and cardiovascular signaling mechanisms.
Gut-brain and systemic communication:
Research indicates VIP is involved in signaling between the gastrointestinal system and central nervous system, making it valuable for studies exploring the gut-brain axis and systemic regulatory networks.
VIP (Vasoactive Intestinal Peptide) – Suggested Use (Research Context)
Typical Dose: 50–200 mcg per day
Route: Subcutaneous injection
Frequency: Once daily
Duration: As directed by a qualified professional